FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100088898> ?p ?o ?g. }

• W2100088898 endingPage "12" @default.
• W2100088898 startingPage "4106" @default.
• W2100088898 abstract "The growth of a large proportion of estrogen receptor-positive breast tumors is stimulated by estrogen and can often be controlled through antiestrogen therapy. Resistance to antiestrogen (AE) therapy can occur while tumors retain the expression of estrogen receptors (ERc) and remain functionally responsive to estrogens. The ability of specific antiestrogen binding sites (AEBS) to prevent AE from interacting with ERc has been examined as a possible mechanism through which this appropriation of AE could interfere with antiestrogen action. Comparisons were performed between uterine preparations where ERc activity exceeded AEBS binding and liver preparations where AEBS binding predominated. Identical estimates of ERc activity were obtained in uterine preparations using either [3H]estradiol or [3H]-4OH-tamoxifen and radioinert diethylstilbestrol (alpha,alpha'-diethyl-4,4'-stilbenediol) to estimate nonspecific binding. AEBS binding was observed only when [3H]-4OH-tamoxifen was used, while binding to Type II sites was resolved only with [3H]estradiol. When excess AEBS activity predominated, analyses with radiolabeled estrogen and antiestrogen present simultaneously showed that virtually all of the antagonist was bound to AEBS with little of the antagonist available to associate with ERc. In an effort to relate these observations to AE resistance per se, ERc and AEBS were measured in MCF-7 human breast cancer cells (ERc-positive, responsive to estrogens and antiestrogens) and in variant AE-insensitive LY-2 human breast cancer cells (ERc-positive, responsive only to estrogens). In AE-resistant LY-2 cells, the ratio of AEBS:ERc was approximately three times greater than in MCF-7 cells. Examination of 128 human breast carcinomas revealed that AEBS activity was present and could exceed ERc activity. Importantly, the partition of significant AE away from ERc was observed in human specimens. These observations identify a biochemical mechanism for antiestrogen resistance through which AE access to ERc can be totally incapacitated while sensitivity to estrogens continues. These observations indicate that AEBS activity, in addition to ERc activity, may provide helpful information for predicting the response of certain cancers to hormonal therapy." @default.
• W2100088898 created "2016-06-24" @default.
• W2100088898 creator A5010882297 @default.
• W2100088898 creator A5013997983 @default.
• W2100088898 creator A5015512498 @default.
• W2100088898 creator A5022568848 @default.
• W2100088898 creator A5023282722 @default.
• W2100088898 creator A5065637970 @default.
• W2100088898 creator A5069992233 @default.
• W2100088898 creator A5091152904 @default.
• W2100088898 date "1992-08-01" @default.
• W2100088898 modified "2023-10-03" @default.
• W2100088898 title "Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity." @default.
• W2100088898 cites W1482458857 @default.
• W2100088898 cites W1484694672 @default.
• W2100088898 cites W1500416364 @default.
• W2100088898 cites W1515245060 @default.
• W2100088898 cites W1594581583 @default.
• W2100088898 cites W1646234539 @default.
• W2100088898 cites W192032079 @default.
• W2100088898 cites W1965881992 @default.
• W2100088898 cites W1979477696 @default.
• W2100088898 cites W1983649348 @default.
• W2100088898 cites W1986753020 @default.
• W2100088898 cites W1988498286 @default.
• W2100088898 cites W1992710311 @default.
• W2100088898 cites W2007722134 @default.
• W2100088898 cites W2007843993 @default.
• W2100088898 cites W2009428030 @default.
• W2100088898 cites W2011244990 @default.
• W2100088898 cites W2024644843 @default.
• W2100088898 cites W2030222611 @default.
• W2100088898 cites W2031749932 @default.
• W2100088898 cites W2042322467 @default.
• W2100088898 cites W2044469448 @default.
• W2100088898 cites W2053619917 @default.
• W2100088898 cites W2075883530 @default.
• W2100088898 cites W2075985173 @default.
• W2100088898 cites W2090957210 @default.
• W2100088898 cites W2093321629 @default.
• W2100088898 cites W2105612963 @default.
• W2100088898 cites W2111648388 @default.
• W2100088898 cites W2123790209 @default.
• W2100088898 cites W2124642053 @default.
• W2100088898 cites W2131437986 @default.
• W2100088898 cites W2153285273 @default.
• W2100088898 cites W2157608591 @default.
• W2100088898 cites W2335512711 @default.
• W2100088898 cites W2409358253 @default.
• W2100088898 cites W2962716900 @default.
• W2100088898 cites W3184192988 @default.
• W2100088898 cites W1967374695 @default.
• W2100088898 cites W2065662573 @default.
• W2100088898 cites W2466004060 @default.
• W2100088898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1638522" @default.
• W2100088898 hasPublicationYear "1992" @default.
• W2100088898 type Work @default.
• W2100088898 sameAs 2100088898 @default.
• W2100088898 citedByCount "25" @default.
• W2100088898 countsByYear W21000888982019 @default.
• W2100088898 countsByYear W21000888982022 @default.
• W2100088898 crossrefType "journal-article" @default.
• W2100088898 hasAuthorship W2100088898A5010882297 @default.
• W2100088898 hasAuthorship W2100088898A5013997983 @default.
• W2100088898 hasAuthorship W2100088898A5015512498 @default.
• W2100088898 hasAuthorship W2100088898A5022568848 @default.
• W2100088898 hasAuthorship W2100088898A5023282722 @default.
• W2100088898 hasAuthorship W2100088898A5065637970 @default.
• W2100088898 hasAuthorship W2100088898A5069992233 @default.
• W2100088898 hasAuthorship W2100088898A5091152904 @default.
• W2100088898 hasConcept C107824862 @default.
• W2100088898 hasConcept C121608353 @default.
• W2100088898 hasConcept C126322002 @default.
• W2100088898 hasConcept C134018914 @default.
• W2100088898 hasConcept C185592680 @default.
• W2100088898 hasConcept C2776067312 @default.
• W2100088898 hasConcept C2777164284 @default.
• W2100088898 hasConcept C2777176818 @default.
• W2100088898 hasConcept C530470458 @default.
• W2100088898 hasConcept C55493867 @default.
• W2100088898 hasConcept C71924100 @default.
• W2100088898 hasConcept C84606932 @default.
• W2100088898 hasConcept C86803240 @default.
• W2100088898 hasConceptScore W2100088898C107824862 @default.
• W2100088898 hasConceptScore W2100088898C121608353 @default.
• W2100088898 hasConceptScore W2100088898C126322002 @default.
• W2100088898 hasConceptScore W2100088898C134018914 @default.
• W2100088898 hasConceptScore W2100088898C185592680 @default.
• W2100088898 hasConceptScore W2100088898C2776067312 @default.
• W2100088898 hasConceptScore W2100088898C2777164284 @default.
• W2100088898 hasConceptScore W2100088898C2777176818 @default.
• W2100088898 hasConceptScore W2100088898C530470458 @default.
• W2100088898 hasConceptScore W2100088898C55493867 @default.
• W2100088898 hasConceptScore W2100088898C71924100 @default.
• W2100088898 hasConceptScore W2100088898C84606932 @default.
• W2100088898 hasConceptScore W2100088898C86803240 @default.
• W2100088898 hasIssue "15" @default.
• W2100088898 hasLocation W21000888981 @default.

• next